Abro I will leave you with one last dreary and tedious post on Permeaderm. They did 328k in Q1 and 435k in Q2 of Permeaderm sales ("other wound care products" on page 23 of 10Q). Most of those sales were undoubtedly to existing accounts taken over from McKesson. So anything over 375-400k in Q3 will be sales to new accounts by Avita. That will tell us both a great deal about the future of Permeaderm.
Inspite of what some may believe, I sincerely hope that and all the other wonderful things foretold in Q calls and webinars come to pass.
I'm actually quite the jovial fellow in real life. But I have taken on the persona of a dreary and tedious 38 year old living in his mother's basement. But like his mom, I do it out of love.
At least I do it in good humour.
Out.
Abro I will leave you with one last dreary and tedious post on...
Add AVH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.65 |
Change
-0.050(1.85%) |
Mkt cap ! $183.5M | |||
| Open | High | Low | Value | Volume |
| $2.64 | $2.68 | $2.63 | $283.6K | 107.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 2206 | $2.65 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.67 | 5477 | 2 |
View Market Depth
| Last trade - 16.10pm 23/08/2024 (20 minute delay) ? |
| AVH (ASX) Chart |